Glial fibrillary acidic protein expression pleomorphic adenoma chordoma astrocytoma comparison antibodies Glial fibrillary acidic protein GFAP major constituent glial cytoplasmic intermediate filaments Glial fibrillary acidic protein expression marker astroglial differentiation origin GFAP expression variety normal neoplastic tissues central nervous system pleomorphic adenomas chordomas bone cartilage coexpression GFAP vimentin neoplastic myoepithelial cells pleomorphic adenomas early chondroid differentiation Glial fibrillary acidic protein expression chondromyxoid chordoid tumors formaldehyde solution-fixed paraffin-embedded sections pleomorphic adenomas chordomas immunoperoxidase method use available monoclonal polyclonal antibodies pleomorphic adenomas chordomas expression GFAP use polyclonal antibody Biomeda Corp Foster City Calif Variable expression GFAP present pleomorphic adenomas chordomas use monoclonal preparations Dakopatts Glostrup Denmark BioGenex Laboratories San Ramon Calif Normal brain tissue astrocytomas controls intensity quality polyclonal monoclonal anti-GFAP antibodies Glial fibrillary acidic protein positivity polyclonal antibody intense monoclonal antibody similar congruent distributions tumor cell types control brain astrocytoma tissues GFAP polyclonal antibody immunoreactive monoclonal antibodies cells chondroid differentiation findings practical application surgical pathology 